These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32153000)

  • 1. Timing of Shunt Insertion in Children with Neural Tube Defects and Hydrocephalus: A Clinical Study.
    Ozgural O; Kahilogullari G; Dogan I; Eroglu U; Yakar F; Kilinc MC; Sayaci EY; Unlu MA
    Turk Neurosurg; 2020; 30(2):194-198. PubMed ID: 32153000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).
    Elbabaa SK; Gildehaus AM; Pierson MJ; Albers JA; Vlastos EJ
    Childs Nerv Syst; 2017 Jul; 33(7):1157-1168. PubMed ID: 28470384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early repair of myelomeningocele and simultaneous insertion of ventriculoperitoneal shunt: technique and results.
    Hubballah MY; Hoffman HJ
    Neurosurgery; 1987 Jan; 20(1):21-3. PubMed ID: 3808266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shunt insertion in newborns with myeloschisis/myelomenigocele and hydrocephalus.
    Yilmaz A; Müslüman AM; Dalgic N; Cavuşoğlu H; Kanat A; Colak I; Aydın Y
    J Clin Neurosci; 2010 Dec; 17(12):1493-6. PubMed ID: 20869250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated Post-Shunt Metopic Synostosis and Neural Tube Defects.
    Abouhassan W; Chao JK; Murthy AS
    J Craniofac Surg; 2018 Jul; 29(5):e492-e497. PubMed ID: 29561489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reviewing the prognostic factors in myelomeningocele.
    Protzenko T; Bellas A; Pousa MS; Protzenko M; Fontes JM; de Lima Silveira AM; Sá CA; Pereira JP; Salomão RM; Salomão JFM; Dos Santos Gomes SC
    Neurosurg Focus; 2019 Oct; 47(4):E2. PubMed ID: 31574474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dual procedures: How combining VP shunt placement for hydrocephalus and myelomeningocele repair in newborns affects complication rates?
    Kadri H; Agha MS; Abouharb R; Mackieh R; Bakleh S; Almasri M; Kadri T
    Neurosurg Rev; 2024 Jul; 47(1):343. PubMed ID: 39031287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus?
    Oktem IS; Menkü A; Ozdemir A
    Turk Neurosurg; 2008 Oct; 18(4):387-91. PubMed ID: 19107685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association between the Timing of Shunt Placement and Shunt Infection in Hydrocephalus Associated with Myelomeningocele.
    Gurbuz MS; Yuksel MO
    Turk Neurosurg; 2020; 30(1):94-98. PubMed ID: 31452179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shunt revision rates in myelomeningocele patients in the first year of life: a retrospective study of 52 patients.
    Alatas I; Canaz G; Kayran NA; Kara N; Canaz H
    Childs Nerv Syst; 2018 May; 34(5):919-923. PubMed ID: 29159427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of External Ventricular Drainage to Reduce the Frequency of Wound Complications in Myelomeningocele Closure.
    McDowell MM; Lee PS; Foster KA; Greene S
    Pediatr Neurosurg; 2018; 53(2):100-107. PubMed ID: 29316543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shunt timing in meningomyelocele and clinical results: analysis of 80 cases.
    İştemen İ; Arslan A; Olguner SK; Açik V; Ökten Aİ; Babaoğlan M
    Childs Nerv Syst; 2021 Jan; 37(1):107-113. PubMed ID: 32632579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporaneous shunting with repair of myelomeningocele.
    Parent AD; McMillan T
    Pediatr Neurosurg; 1995; 22(3):132-5; discussion 136. PubMed ID: 7786805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of simultaneous shunting to delayed shunting in infants with myelomeningocele in terms of shunt infection rate.
    Arslan M; Eseoglu M; Gudu BO; Demir I; Kozan A; Gokalp A; Sosuncu E; Kiymaz N
    Turk Neurosurg; 2011; 21(3):397-402. PubMed ID: 21845578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of the need for cerebrospinal fluid diversion in patients with myelomeningocele.
    Phillips BC; Gelsomino M; Pownall AL; Ocal E; Spencer HJ; O'Brien MS; Albert GW
    J Neurosurg Pediatr; 2014 Aug; 14(2):167-72. PubMed ID: 24877604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous repair of myelomeningocele and shunt insertion.
    Machado HR; Santos de Oliveira R
    Childs Nerv Syst; 2004 Feb; 20(2):107-9. PubMed ID: 14657994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular shunt survival in children with neural tube defects.
    Liptak GS; Masiulis BS; McDonald JV
    Acta Neurochir (Wien); 1985; 74(3-4):113-7. PubMed ID: 3984790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shunt complications in the first postoperative year in children with meningomyelocele.
    Caldarelli M; Di Rocco C; La Marca F
    Childs Nerv Syst; 1996 Dec; 12(12):748-54. PubMed ID: 9118142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vanishing shunt valve.
    Joshi KC; Khanapure K; Jagannatha AT; Varma RG
    Childs Nerv Syst; 2015 Nov; 31(11):2207-9. PubMed ID: 26099231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome Analysis of Patients of Congenital Hydrocephalus with Ventriculoperitoneal Shunt at a Tertiary Care Hospital in North India.
    Bawa M; Dash V; Mahalik S; Rao KLN
    Pediatr Neurosurg; 2019; 54(4):233-236. PubMed ID: 31291639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.